^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ClarityDX Prostate®

    Company:
    Nanostics
    Type:
    CE Marked
    Details
    Evidence

    News

    4ms
    APCaRI-05: Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer (clinicaltrials.gov)
    P=N/A; Recruiting --> Active, not recruiting | Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Oct 2023 --> Mar 2024
    Trial completion date • Trial primary completion date • Enrollment closed • Reflex
    |
    ClarityDX Prostate®
    7ms
    Nanostics launches ClarityDX prostate test in Alberta to Significantly improve prostate cancer screening (Nanostics Press Release)
    "Nanostics is thrilled to announce the availability of the ClarityDX Prostate test at its newly accredited clinical lab in Edmonton, Alberta. This innovative blood test marks a significant advancement in prostate cancer screening. It provides critical support to men, aged 40 to 75, and their physicians in making more informed decisions, with 3X the accuracy, about whether a biopsy is required following a high prostate-specific antigen (PSA) test result."
    Commercial
    |
    ClarityDX Prostate®
    7ms
    Nanostics receives provisional CPSA accreditation for its clinical laboratory (BioSpace)
    "Nanostics Inc...announced today that the College of Physicians and Surgeons of Alberta (CPSA) granted provisional accreditation to Nanostics Clinical Laboratory in Edmonton, Alberta, Canada."
    Regulatory
    |
    ClarityDX Prostate®
    over1year
    Nanostics Receives CE Mark for its ClarityDX Prostate Test to Detect Clinically Significant Prostate Cancer (Canada Newswire)
    "Nanostics Inc...is excited to announce today that it has received the CE-IVD Mark for its ClarityDX Prostate® test. This regulatory milestone allows Nanostics to market and sell ClarityDX Prostate® in Europe, as well as other countries that require the CE Mark for market access."
    European regulatory
    |
    ClarityDX Prostate®